Planoptik (P4O) H2 2024 earnings summary

Executive summary

• Revenue declined by 10.5% year-over-year to €11.86 million, mainly due to cyclical effects and inventory reductions by major customers in response to normalized supply chains and lower inflation.

• EBITDA dropped to €1.76 million from €3.07 million, and EBIT fell to €1.02 million from €2.32 million, reflecting both lower sales and increased costs.

• Net income decreased to €0.70 million from €1.67 million, with EPS at €0.15 versus €0.37 in the prior year.

• Despite the downturn, the company remains financially robust, with a strong equity ratio and positive operating cash flow.

• Expansion of production capacity in Hungary and investments in new technologies position the company for future growth.

Financial highlights

• Revenue: €11.86 million (2023: €13.25 million; 2022: €11.47 million).

• EBITDA: €1.76 million (2023: €3.07 million); EBITDA margin: 14.8% (2023: 23.2%).

• EBIT: €1.02 million (2023: €2.32 million); EBIT margin: 8.6% (2023: 17.5%).

• Net income: €0.70 million (2023: €1.67 million); EPS: €0.15 (2023: €0.37).

• Equity ratio: 77.4% (2023: 74.5%).

• Cash and cash equivalents: €5.21 million (2023: €4.72 million).

• Operating cash flow: €1.65 million (2023: €2.68 million).

Outlook and guidance

• Management expects revenue to rise in 2025 to between €12.0 million and €13.0 million, with further growth anticipated in 2026 as market conditions improve and new products contribute.

• Only a moderate increase in EBT is forecast for 2025 due to one-off costs related to the transition to the regulated market and ongoing expansion.

• Growth prospects are supported by the anticipated end of customer inventory reductions and recovery in demand, especially in sensor and advanced packaging markets.